Dr. Martin Zügel named Chief Executive Officer of Merz Pharmaceuticals
Dr. Martin Zügel was named CEO for Merz Pharmaceuticals and the dental business of the Merz Group, effective April 1, 2005. He will specifically focus on corporate strategy, new business and expansion of the company internationally, to ensure a continued organic company growth.
Dr. Zügel is a molecular biologist and holds a Ph.D. in medicine from the University of Tübingen in Germany. In his new role, Dr. Zügel will bring to Merz his leadership and international expertise he developed during his tenure at Boehringer Mannheim/Hoffmann La Roche AG (Mannheim/Grenzach, Germany) and B. Braun Melsungen AG (Melsungen, Germany). Most recently, Dr. Zügel was a member of the board at B. Braun and responsible for the Hospital Care division and the Asia Pacific region.
Most read news
Other news from the department people

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.